Sutro Biopharma, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
STRO chart
What traders are saying about $STRO
Latest postsSutro Biopharma, Inc. news
- A passive stake above 5% in Sutro Biopharma (STRO) is reported by five parties.
Stock Titan ·
- Sutro Biopharma, Inc. (STRO) Seasonal returns chart
Yahoo Finance UK ·
- Merck abandons Sutro-partnered IL-2 drug in ‘routine pipeline prioritization’
Fierce Biotech ·
- Here's Why Sutro Biopharma (STRO) is Poised for a Turnaround After Losing 34.2% in 4 Weeks
Yahoo Finance ·
- Sutro Biopharma to present at multiple investor conferences in November and December 2026
Pluang ·
- Sutro Biopharma to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Five investor conferences will include Sutro Biopharma in New York and London.
Stock Titan ·
- Down 39.8% in 4 Weeks, Here's Why Sutro Biopharma (STRO) Looks Ripe for a Turnaround
Yahoo Finance ·
- Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance ·
- Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
Yahoo Finance ·
- Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
Yahoo Finance ·
- Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
Yahoo Finance ·
Sutro Biopharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $102.5M | $62.0M | $153.7M | $67.8M |
| Net income | -$191.0M | -$227.0M | -$107.0M | -$119.2M |
| Diluted EPS | $-22.49 | $-29.40 | $-1.78 | $-2.35 |
| Total assets (year end) | $173.8M | $387.2M | $470.7M | $406.9M |
| Cash and equivalents (year end) | $58.1M | $190.3M | $69.3M | $47.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sutro Biopharma, Inc.
- Ticker
- STRO (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Fiscal year end
- December 31
- SEC CIK
- 1382101
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
Frequently asked questions
What exchange is Sutro Biopharma, Inc. listed on?
Sutro Biopharma, Inc. trades on the Nasdaq under the ticker symbol STRO.
What industry is Sutro Biopharma, Inc. in?
Sutro Biopharma, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Sutro Biopharma, Inc. headquartered?
Sutro Biopharma, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Sutro Biopharma, Inc.'s fiscal year end?
Sutro Biopharma, Inc.'s fiscal year ends on December 31.
How much revenue did Sutro Biopharma, Inc. report?
Sutro Biopharma, Inc. reported $102.5M in revenue for calendar year 2025, according to its SEC filings.